TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ZYME

Zymeworks Inc.

Healthcare · Biotechnology

27.50$ +4.7% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Zymeworks Inc. (ZYME) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 397 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ZYME
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
556 581 554 516 487 463 426 408 397 347 478 397
375 413 394 383 344 300 306 296 292 233 386 298
94 158 115 71 122 66 76 98 65 41 244 179
295 374 345 330 297 226 265 281 252 229 365 271
67 19 31 32 24 56 25 2.6 29 4.6 4.7 5.9
0.0 0.0
39
12 12 12 12 12 12 12 12 12 12,016 12 12
26 25 25 7.5 6.6 4.6 3.4 2.0 1.4 1,350 1.2 1.0
132 116 116 109 120 124 101 74 77 78 315 317
73 56 57 55 84 88 65 39 42 42 36 47
3.8 4.3 4.2 2.8 2.9 2.7 3.3 3.6 3.4 3.5 3.3 3.3
11 6.2 2.5 1.7 3.4 3.9 5.2 0.0 1.3 4.4 30 27
424 465 438 406 367 339 325 335 320 269 164 80
-663 -677 -709 -747 -798 -830 -853 -851 -886 -953 -1,074 -1,171
71 71 76 76 76 76 75 77 76 75 75 73

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?